Phaseline

Companies › Climb Bio

Climb Bio: clinical trials, targets and expected readouts

2 active drug programs in 5 registered trials: 4 Phase 1, 1 Phase 2; Genitourinary, Hematology, Immunology; next expected readout Apr 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Budoprutug (TNT119)–Phase 2Primary Membranous Nephropathy; Systemic Lupus Erythematosus; Immune Thrombocytopenia (ITP); Systemic Lupus ErthematosusApr 2027
CLYM116–Phase 1Healthy Volunteers–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT07248865CLYM116Phase 1Healthy VolunteersGenitourinaryJul 2026
NCT07011043Budoprutug (TNT119)Phase 1Systemic Lupus ErythematosusImmunologyApr 2027
NCT07043946Budoprutug (TNT119)Phase 1Immune Thrombocytopenia (ITP)HematologyAug 2027
NCT07564596Budoprutug (TNT119)Phase 1Systemic Lupus ErthematosusImmunologySep 2027
NCT07096843Budoprutug (TNT119)Phase 2Primary Membranous NephropathyGenitourinaryOct 2027

From the company's SEC filings

Cash and short-term investments of $205m on 2026-09-30; operating cash outflow about $50m a year; runway about 50 months at that burn, to Nov 2030; 1 of 1 coming phase 2-3 readouts fall inside that runway

Press releases filed as 8-K in the last year:

Agreements filed with the SEC (item 1.01), last two years

Specialist investors

Held by 12 of the 39 life-science funds Phaseline follows through their 13F filings. Who holds what.

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

Omeros Akebia Therapeutics Jade Biosciences Neurocrine Switzerland ScinnoHub Pharmaceutical

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.